Nocturia clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • Ancillary Nocturnal Urinary Symptoms Analyses for TRIUMPH

    open to eligible females ages 60 years and up

    The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed tocompare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonistbladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes in ambulatory older women with urgency-predominant urinaryincontinence and either normal or mildly impaired cognitive function at baseline.

    San Francisco, California

Our lead scientists for Nocturia research studies include .

Last updated: